Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Reviva Pharmaceuticals Holdings, Inc. RVPHW NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
28/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Reviva Pharmaceuticals Holdings, Inc. (RVPHW) is a Biotechnology company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 25/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Net income is $19.9T (loss), growing at -22131995%/yr. Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).

Balance sheet: total debt is $406.9B against $8.6T equity (Debt-to-Equity (D/E) ratio 0.05, conservative). Current ratio is 2.08 (strong liquidity). Debt-to-assets is 2.6%. Total assets: $15.9T.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 67/100 (Partial), Moat 28/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

RVPHW SharesGrow Score Overview

37/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — RVPHW

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
RVPHW: +0%/yr revenue is, -22131995%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
~
HEALTH Partial
67/100
Balance sheet RVPHW: Debt-to-Equity (D/E) ratio 0.05 (conservative), Current ratio is 2.08 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
28/100
RVPHW: Gross margin is 0% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 28/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.003-0.041
Volume303.38K
Avg Volume (30D)75.8K
Market Cap$343.91K
Beta (1Y)-0.03
Share Statistics
EPS (TTM)-5.48
Shares Outstanding$3.63M
IPO Date2018-10-18
Employees14
CEOLaxminarayan Bhat
Financial Highlights & Ratios
EBITDA$-20.2T
Net Income$-19.86T
Operating Income$-20.2T
Total Cash$14.44T
Total Debt$406.88B
Net Debt$-14.03T
Total Assets$15.92T
Price / Earnings (P/E)-0
Analyst Forecast
Company Info
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS76152G1186

Price Chart

Track all markets on TradingView
RVPHW
Reviva Pharmaceuticals Holdings, Inc. ↗  ·  NASDAQ Capital Marke
Healthcare • Biotechnology
0.00 52WK RANGE 0.04

People Also View

RVPH
RVPH
Reviva Pharmaceuticals Holdings, Inc.
$0.86
-1.44%
 ATNFW
ATNFW
CannBioRx Life Sciences Corp.
$0.43
-6.52%
 CLNNW
CLNNW
Clene Inc.
$0.00
-28.00%
 LIXTW
LIXTW
Lixte Biotechnology Holdings, Inc.
$0.02
+100.00%
 ARTLW
ARTLW
Artelo Biosciences, Inc.
$0.01
+0.00%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message